ASLAN Pharmaceuticals submits clinical trial authorisation application for first in man studies for ASLAN004

This article was originally published here

ASLAN Pharmaceuticals has submitted a clinical trial authorisation application with the Singapore Health Sciences Authority (HSA) to initiate a phase 1 trial of ASLAN004.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply